MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$797M
Free Cash flow
$417M
Unit: Million (M) dollars
Positive Cash Flow Breakdown
Net income
Deferred income tax expense
Other items, net
Others
Negative Cash Flow Breakdown
Repurchases of common stock
Accounts payable, accrued expens...
Distributions paid to noncontrol...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
1,045
906
644
1,723
Depreciation and amortization
215
229
231
632
Deferred income tax expense
137
-40
-42
51
Stock-based compensation expense
44
25
25
79
Impairment and restructuring charges, and acquisition-related costs
31
24
64
66
Litigation and investigation costs
-3
-27
-30
-34
Net losses (gains) on sales, consolidation and deconsolidation of facilities
33
1
-5
4
Loss from early extinguishment of debt
-
-
-4
0
Equity in earnings of unconsolidated affiliates, net of distributions received
40
-29
21
13
Amortization of debt discount and debt issuance costs
6
5
5
18
Net gains from the sale of investments and long-lived assets
-
1
2
2
Other items, net
12
-2
3
3
Accounts receivable
5
28
48
-68
Inventories and other current assets
158
-407
15
58
Income taxes
165
-259
40
-15
Accounts payable, accrued expenses and other current liabilities
-493
-145
-28
237
Other long-term liabilities
36
0
-41
50
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements
27
57
37
84
Net cash provided by operating activities
585
1,641
731
2,809
Purchases of property and equipment
168
180
364
646
Purchases of businesses or joint venture interests, net of cash acquired
9
121
42
266
Proceeds from sales of facilities and other assets
4
2
20
18
Proceeds from sales of marketable securities and long-term investments
29
22
19
74
Purchases of marketable securities and long-term investments
51
26
21
69
Other items, net
8
14
1
-3
Net cash used in investing activities
-203
-317
-389
-886
Repayments of borrowings
26
33
2,282
90
Proceeds from borrowings
14
14
2,255
21
Repurchases of common stock
1,042
318
198
1,188
Debt issuance costs
-
-
32
-
Distributions paid to noncontrolling interests
201
197
224
585
Proceeds from the sale of noncontrolling interests
9
6
15
27
Purchases of noncontrolling interests
9
549
4
88
Advances from managed care payers
-
-
0
0
Repayments of advances from managed care payers
0
0
-1
33
Taxes paid related to net share settlement, net of proceeds from shares issued under stock-based compensation plans
-3
86
4
47
Other items, net
73
-77
39
16
Net cash used in financing activities
-1,179
-1,240
-434
-1,967
Net decrease in cash and cash equivalents
-797
84
-92
-44
Cash and cash equivalents at beginning of period
2,967
2,883
2,975
3,019
Cash and cash equivalents at end of period
2,170
2,967
2,883
2,975
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$1,045M
Depreciation and
amortization
$215M
Deferred income tax
expense
$137M
Stock-based compensation
expense
$44M
Other long-term
liabilities
$36M
Impairment and
restructuring charges, and...
$31M
Amortization of debt discount
and debt issuance...
$6M
Litigation and
investigation costs
-$3M
Net cash provided by
operating activities
$585M
Canceled cashflow
$933M
Net decrease in cash
and cash...
-$797M
Canceled cashflow
$585M
Other items, net
$73M
Proceeds from borrowings
$14M
Proceeds from the sale of
noncontrolling interests
$9M
Taxes paid related to
net share...
-$3M
Proceeds from sales of
marketable securities and...
$29M
Proceeds from sales of
facilities and other assets
$4M
Accounts payable,
accrued expenses and...
-$493M
Income taxes
$165M
Inventories and other
current assets
$158M
Equity in earnings of
unconsolidated affiliates, net...
$40M
Net losses (gains)
on sales,...
$33M
Payments for
restructuring charges,...
$27M
Other items, net
$12M
Accounts receivable
$5M
Net cash used in
financing activities
-$1,179M
Canceled cashflow
$99M
Net cash used in
investing activities
-$203M
Canceled cashflow
$33M
Repurchases of common stock
$1,042M
Distributions paid to
noncontrolling interests
$201M
Repayments of borrowings
$26M
Purchases of
noncontrolling interests
$9M
Purchases of property and
equipment
$168M
Purchases of marketable
securities and long-term...
$51M
Purchases of businesses or
joint venture...
$9M
Other items, net
$8M
Buy us a coffee
TENET HEALTHCARE CORP (THC)
TENET HEALTHCARE CORP (THC)